Nodal Marginal Zone Lymphoma with Eosinophilic Dermatosis of Haematologic Malignancy: A Case Report

Tan S, Choong DJ, Tan E. A systematic review of the management of eosinophilic dermatosis of hematological malignancy. Int J Dermatol 2024; 63: 1164–1171. DOI: https://doi.org/10.1111/ijd.17221

Rossi D, Bertoni F, Zucca E. Marginal-Zone Lymphomas. N Engl J Med 2022; 386: 568–581. DOI: https://doi.org/10.1056/NEJMra2102568

Jiang S, Manandhar U, Zheng KP, Liu Q, Liang P, Song JQ. A case of nodal marginal zone lymphoma with hypersensitivity to mosquito bites as initial symptom. J Cutan Pathol 2019; 46: 769–774. DOI: https://doi.org/10.1111/cup.13497

Yoon TY, Kim YG, Kim JW, Kim MK. Nodal marginal zone lymphoma in association with hydroa vacciniforme-like papulovesicular eruption, hypersensitivity to mosquito bites and insect bite-like reaction. Br J Dermatol 2005; 153: 210–212. DOI: https://doi.org/10.1111/j.1365-2133.2005.06684.x

Weed RI. Exaggerated delayed hypersensitivity to mosquito bites in chronic lymphocytic leukemia. Blood 1965; 26: 257–268. DOI: https://doi.org/10.1182/blood.V26.3.257.257

Barzilai A, Shpiro D, Goldberg I, Yacob-Hirsch Y, Diaz-Cascajo C, Meytes D, et al. Insect bite-like reaction in patients with hematologic malignant neoplasms. Arch Dermatol 1999; 135: 1503. DOI: https://doi.org/10.1001/archderm.135.12.1503

Farber MJ, La Forgia S, Sahu J, Lee JB. Eosinophilic dermatosis of hematologic malignancy. J Cutan Pathol 2012; 39: 690–695. DOI: https://doi.org/10.1111/j.1600-0560.2012.01906.x

Cohen PR. Hematologic-related malignancy-induced eosinophilic dermatosis (He Remained): an eosinophilic dermatosis predominantly associated with chronic lymphocytic leukemia. J Am Acad Dermatol 2020; 82: e13–e14. DOI: https://doi.org/10.1016/j.jaad.2019.08.062

Yamada M, Ishikawa Y, Imadome KI. Hypersensitivity to mosquito bites: a versatile Epstein–Barr virus disease with allergy, inflammation, and malignancy. Allergol Int 2021; 70: 430–438. https://doi:10.1016/j.alit.2021.07.002 DOI: https://doi.org/10.1016/j.alit.2021.07.002

Leiferman KM, Peters MS. Reflections on eosinophils and flame figures: where there’s smoke there’s not necessarily Wells syndrome. Arch Dermatol 2006; 142: 1215–1218. DOI: https://doi.org/10.1001/archderm.142.9.1215

Maglie R, Ugolini F, De Logu F, Nassini R, Simi S, Nardiello P, et al. Overexpression of helper T cell type 2-related molecules in the skin of patients with eosinophilic dermatosis of hematologic malignancy. J Am Acad Dermatol 2022; 87: 761–770. DOI: https://doi.org/10.1016/j.jaad.2021.07.007

Maglie R, Ugolini F, De Logu F, Simi S, Senatore S, Montefusco F, et al. Dupilumab for the treatment of recalcitrant eosinophilic dermatosis of haematologic malignancy. J Eur Acad Dermatol Venereol 2021; 35: e501–e503. DOI: https://doi.org/10.1111/jdv.17232

Lor M, Gates G, Yu Y. Eosinophilic dermatosis of hematologic malignancy effectively controlled with omalizumab maintenance therapy. Dermatol Ther 2020; 33: e14206. DOI: https://doi.org/10.1111/dth.14206